Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9209297rdf:typepubmed:Citationlld:pubmed
pubmed-article:9209297lifeskim:mentionsumls-concept:C0020094lld:lifeskim
pubmed-article:9209297lifeskim:mentionsumls-concept:C0033144lld:lifeskim
pubmed-article:9209297lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:9209297lifeskim:mentionsumls-concept:C0022341lld:lifeskim
pubmed-article:9209297pubmed:dateCreated1997-8-7lld:pubmed
pubmed-article:9209297pubmed:abstractTextThe Nagasaki Prefecture, Japan (population: 1.5 million), is one of the hot endemic foci of Human T-lymphotropic virus type 1 (HTLV-1). Prevalence of HTLV-1 carriers are approximately 10% in the age group over 40 years old (40,000 individuals), approximately 10 times of the national average. Annual registry of adult T-cell leukemia (ATL) in the Prefecture is approximately 60 cases (estimated incidence: 100 cases), or a half percent of total deaths. A effective measure to control the endemic cycle of HTLV-1 has been imperative, since practical ways to prevent or control ATL are not available. A prefecture wide intervention at Nagasaki by refrain from breast-feeding blocked approximately 80% of mother-to-child transmission of HTLV-1.lld:pubmed
pubmed-article:9209297pubmed:languageenglld:pubmed
pubmed-article:9209297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9209297pubmed:citationSubsetIMlld:pubmed
pubmed-article:9209297pubmed:statusMEDLINElld:pubmed
pubmed-article:9209297pubmed:monthAprlld:pubmed
pubmed-article:9209297pubmed:issn0887-6924lld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:HinoSSlld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:MiyataHHlld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:MiyamotoTTlld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:TsujiYYlld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:YamabeTTlld:pubmed
pubmed-article:9209297pubmed:authorpubmed-author:KatamineSSlld:pubmed
pubmed-article:9209297pubmed:issnTypePrintlld:pubmed
pubmed-article:9209297pubmed:volume11 Suppl 3lld:pubmed
pubmed-article:9209297pubmed:ownerNLMlld:pubmed
pubmed-article:9209297pubmed:authorsCompleteYlld:pubmed
pubmed-article:9209297pubmed:pagination57-9lld:pubmed
pubmed-article:9209297pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:meshHeadingpubmed-meshheading:9209297-...lld:pubmed
pubmed-article:9209297pubmed:year1997lld:pubmed
pubmed-article:9209297pubmed:articleTitlePrimary prevention of HTLV-1 in Japan.lld:pubmed
pubmed-article:9209297pubmed:affiliationDepartment of Virology, Faculty of Medicine, Tottori University, Yonago, Japan.lld:pubmed
pubmed-article:9209297pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9209297lld:pubmed